Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 150 entries
View as:

Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02148185 Org: User:
Start: 05/31/14 End: 06/30/14 Due: 06/30/15

Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan

Phase: N/A Priority: Normal
NCT ID: NCT03439137 Org: User:
Start: 02/14/18 End: 07/16/19 Due: 07/16/20

Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS

Phase: N/A Priority: Normal
NCT ID: NCT05568615 Org: User:
Start: 10/26/22 End: 06/27/23 Due: 06/27/24

Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT04176224 Org: User:
Start: 04/17/19 End: 09/04/19 Due: 09/04/20

Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00971243 Org: User:
Start: 08/31/09 End: 04/30/11 Due: 04/30/12

Monotherapy Study of MP-513 in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00998881 Org: User:
Start: 09/30/09 End: 06/30/10 Due: 06/30/11

Drug Interaction Study of Warfarin and MT-3995

Phase: N/A Priority: Normal
NCT ID: NCT02531568 Org: User:
Start: 06/30/15 End: 09/30/15 Due: 09/30/16

A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT03570957 Org: User:
Start: 07/17/18 End: 12/27/18 Due: 12/27/19

Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01585155 Org: User:
Start: 02/29/12 End: 09/30/14 Due: 09/30/15

A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT00630058 Org: User:
Start: 04/30/08 End: 03/31/09 Due: 03/31/10

A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01425632 Org: User:
Start: 08/31/11 End: 12/31/11 Due: 12/31/12

Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02220920 Org: User:
Start: 08/31/14 End: 07/31/15 Due: 07/31/16

Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）

Phase: N/A Priority: Normal
NCT ID: NCT00412867 Org: User:
Start: 12/31/06 End: 06/30/08 Due: 06/30/09

Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT02118961 Org: User:
Start: 04/30/14 End: 08/31/14 Due: 08/31/15

Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01413204 Org: User:
Start: 07/31/11 End: 08/31/12 Due: 08/31/13

Long-Term Study of MP-214 in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01626872 Org: User:
Start: 09/30/12 End: 10/31/16 Due: 10/31/17

Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00691028 Org: User:
Start: 09/30/05 End: 05/31/07 Due: 05/31/08

Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy

Phase: N/A Priority: Normal
NCT ID: NCT04254913 Org: User:
Start: 01/24/20 End: 04/22/20 Due: 04/22/21

Clinical Pharmacology Study of MP-424

Phase: N/A Priority: Normal
NCT ID: NCT01766167 Org: User:
Start: 02/28/13 End: 04/30/13 Due: 04/30/14

Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01987843 Org: User:
Start: 09/30/13 End: 11/30/14 Due: 11/30/15

A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia

Phase: N/A Priority: Normal
NCT ID: NCT00542386 Org: User:
Start: 12/31/07 End: 11/30/09 Due: 11/30/10

A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

Phase: N/A Priority: Normal
NCT ID: NCT00506441 Org: User:
Start: 09/30/07 End: 09/30/09 Due: 09/30/10

A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02675309 Org: User:
Start: 02/29/16 End: 03/31/16 Due: 03/31/17

A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia

Phase: N/A Priority: Normal
NCT ID: NCT00416520 Org: User:
Start: 06/30/07 End: 11/30/09 Due: 11/30/10

Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT01753557 Org: User:
Start: 12/31/12 End: 11/30/14 Due: 11/30/15